Clinical Trial of Hydroquinone Ointment on Pigmentation after Contact Dermatitis
-
- OOSHIMA Tsuneo
- Ooshima Private Clinic
-
- OOSHIMA Keiko
- Ooshima Private Clinic
-
- MORIKAWA Fujio
- Shiseido Scientific Research Center
-
- TAKAHASHI Kenjiro
- Takahashi Pharmacy
Bibliographic Information
- Other Title
-
- ハイドロキノン外用剤による色素沈着症の治療
- ハイドロキノン外用剤による色素沈着症の治療--後天的炎症後色素沈着について
- ハイドロキノン ガイヨウザイ ニヨル シキソ チンチャクショウ ノ チリョウ
- ヒドロキノン外用剤による色素沈着症の治療 後天的炎症後色素沈着
- —後天的炎症後色素沈着について—
Search this article
Description
Hydroquinone is known to a superexcellent melanoanalysis agent both in vivo and in vitro. Hydroquinone formulated in ointment is found to be austere, and side effects of ointment used for depigmentation are greatly censured because of stability. In the study, a new hydroquinone ointment was developed by formulating L-ascorbic acid (0.3%) as a reducing agent and hydrocortisone acetate (1%) as an anti-inflammatory agent which was seen proven to be safe for repeated applications without any side effects. This ointment has been proven to be stable for a fairly long time and effective therapy to pigmentation as post-inflammation.
Journal
-
- Nishi Nihon Hifuka
-
Nishi Nihon Hifuka 42 (1), 115-118, 1980
Western Division of Japanese Dermatological Association
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679275806080
-
- NII Article ID
- 130004472627
-
- NII Book ID
- AN00183881
-
- ISSN
- 18804047
- 03869784
-
- NDL BIB ID
- 2210011
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed